The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
44 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $86,484,596 in first-year total cost, median $1,875,727.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-F (M1)]4
- Special Emphasis Panel[ZCA1 RPRB-L (M1)]4
- Special Emphasis Panel[ZCA1 RPRB-F (O1)]3
- Special Emphasis Panel[ZCA1 RTRB-R (J1)]3
- Special Emphasis Panel[ZCA1 RTRB-R (M1)]3
Most frequent institutions
- DANA-FARBER CANCER INST4
- OHIO STATE UNIVERSITY3
- MASSACHUSETTS GENERAL HOSPITAL2
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE2
- SLOAN-KETTERING INST CAN RESEARCH2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Epigenetic Control and Genome Organization1P01CA240685-01A1 | STEIN, GARY S.STEIN, JANET L | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $1,678,923 | ZCA1 |
| 2020 | Understanding and Overcoming T cell Immunosuppression in Glioblastoma1P01CA236749-01A1 | CHIOCCA, E. ANTONIOREARDON, DAVID A | BRIGHAM AND WOMEN'S HOSPITAL, MA | $3,024,895 | ZCA1 |
| 2020 | Targeting the Chemokine System to Sensitize Tumors to Immunotherapy1P01CA234212-01A1 | KALINSKI, PAWEL | ROSWELL PARK CANCER INSTITUTE CORP, NY | $2,808,311 | ZCA1 |
| 2020 | Combination Therapies to Defeat Melanoma Resistance1P01CA244118-01A1 | RIBAS, ANTONI | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,574,738 | ZCA1 |
| 2020 | Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response1P01CA250972-01 | MORRIS, ZACHARY SCOTTWEICHERT, JAMEY P | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,490,943 | ZCA1 |
| 2020 | Increasing the therapeutic index of brain tumor treatment through innovative FLASH radiotherapy1P01CA244091-01 | LIMOLI, CHARLES | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $2,174,975 | ZCA1 |
| 2020 | Sex-based Differences in Glioma1P01CA245705-01A1 | BARNHOLTZ-SLOAN, JILL SLATHIA, JUSTIN D. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $2,156,584 | ZCA1 |
| 2020 | Clinical Care Gaps and Unmet Needs in Adolescent and Young Adult (AYA) Cancers1P01CA233432-01A1 | CHUBAK, JESSICAHAHN, ERIN ELIZABETHKEEGAN, THERESA H MKUSHI, LAWRENCE HNICHOLS, HAZEL B | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $2,147,232 | ZCA1 |
| 2020 | Targeted Sphingolipid Metabolism for Treatment of AML2P01CA171983-06A1 | KESTER, MARKLOUGHRAN, THOMAS P. | UNIVERSITY OF VIRGINIA, VA | $2,054,089 | ZCA1 |
| 2020 | Development of Novel Therapeutic Strategies in Human Leukemias2P01CA066996-21 | EBERT, BENJAMIN LEVINE | DANA-FARBER CANCER INST, MA | $2,012,011 | ZCA1 |
| 2020 | Determinants of Liver Metastasis1P01CA233452-01A1 | BHOWMICK, NEIL A.LU, SHELLY CHI-LOO | CEDARS-SINAI MEDICAL CENTER, CA | $1,884,342 | ZCA1 |
| 2020 | Polymerase theta, genome instability, and cancer1P01CA247773-01 | RAMSDEN, DALE A | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $1,856,436 | ZCA1 |
| 2020 | Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge2P01CA078902-22 | SANDMAIER, BRENDA MARIESTORB, RAINER F. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $1,846,796 | ZCA1 |
| 2020 | Retrovirus Models of Cancer2P01CA100730-16A1 | GREEN, PATRICK LEE | OHIO STATE UNIVERSITY, OH | $1,837,557 | ZCA1 |
| 2020 | exRNA in colorectal carcinoma: biogenesis and function1P01CA229123-01A1 | WEAVER, ALISSA M | VANDERBILT UNIVERSITY, TN | $1,793,739 | ZCA1 |
| 2020 | Role of Histone and Histone-like Mutations in the Oncogenesis of Human Cancers2P01CA196539-06 | ALLIS, CHARLES DAVID | ROCKEFELLER UNIVERSITY, NY | $1,790,523 | ZCA1 |
| 2020 | DNA double-strand break repair, chromosome translocations and cancer2P01CA174653-06 | GAUTIER, JEAN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $1,782,789 | ZCA1 |
| 2020 | New therapeutic vulnerabilities in breast cancer1P01CA250959-01 | POLYAK, KORNELIA | DANA-FARBER CANCER INST, MA | $1,772,970 | ZCA1 |
| 2020 | The Biology of Prostate Cancer Skeletal Metastases2P01CA093900-16 | KELLER, EVAN T | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,517,805 | ZCA1 |
| 2020 | Discovery of Anticancer Agents of Diverse Natural Origin2P01CA125066-11A1 | KINGHORN, ALAN DOUGLAS | OHIO STATE UNIVERSITY, OH | $1,472,706 | ZCA1 |
| 2020 | Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma1P01CA236585-01A1 | EIBL, GUIDO ERWIN MICHAEL | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,159,739 | ZCA1 |
| 2019 | Precision Delivery and Imaging to Enhance Solid Tumor Therapy1P01CA221775-01A1 | SCHNITZER, JAN EUGENIUSZ | PROTEOGENOMICS RESEARCH INSTIT/SYS/ MED, CA | $2,788,878 | ZCA1 |
| 2019 | Immune Modulation After Allogeneic HCT1P01CA229092-01A1 | SOIFFER, ROBERT JON | DANA-FARBER CANCER INST, MA | $2,779,234 | ZCA1 |
| 2019 | Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma2P01CA049605-29A1 | NEGRIN, ROBERT S | STANFORD UNIVERSITY, CA | $2,745,884 | ZCA1 |
| 2019 | Immunobiology of Allogeneic Hematopoietic Cell Transplantation2P01CA023766-39A1 | VAN DEN BRINK, MARCEL R M | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,573,596 | ZCA1 |
| 2019 | Improving Uptake of Cervical Cancer Prevention Services in Appalachia1P01CA229143-01A1 | ANDERSON, ROGER T.DIGNAN, MARK BKENNEDY-REA, STEPHENIE KAYPASKETT, ELECTRA D. | OHIO STATE UNIVERSITY, OH | $2,563,376 | ZCA1 |
| 2019 | Targeted Therapies in Melanoma2P01CA114046-11A1 | HERLYN, MEENHARD FWEERARATNA, ASHANI T | WISTAR INSTITUTE, PA | $2,538,781 | ZCA1 |
| 2019 | Immunobiology and Immune Therapy for Merkel Cell Carcinoma1P01CA225517-01A1 | NGHIEM, PAUL | UNIVERSITY OF WASHINGTON, WA | $2,517,378 | ZCA1 |
| 2019 | Bone Marrow Transplantation in Human Disease1P01CA225618-01A1 | JONES, RICHARD J | JOHNS HOPKINS UNIVERSITY, MD | $2,269,507 | ZCA1 |
| 2019 | Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma2P01CA118816-11A1 | CHANG, SUSAN MVIGNERON, DANIEL B | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,157,708 | ZCA1 |
| 2019 | Genomics Of Acute Myeloid Leukemia.2P01CA101937-15A1 | LEY, TIMOTHY J. | WASHINGTON UNIVERSITY, MO | $2,084,756 | ZCA1 |
| 2019 | The impact of changes in chromatin architecture on cancer phenotypes and tumor progression1P01CA229086-01A1 | SKOK, JANE AMANDA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,065,700 | ZCA1 |
| 2019 | The Impact of DNA Damage Repair Abnormalities in Prostate Cancer1P01CA228696-01A1 | KANTOFF, PHILIP WPOMERANTZ, MARK M. | SLOAN-KETTERING INST CAN RESEARCH, NY | $1,929,187 | ZCA1 |
| 2019 | Informed Combination Strategies for Peripheral T-cell Lymphomas1P01CA233412-01A1 | WEINSTOCK, DAVID MARC | DANA-FARBER CANCER INST, MA | $1,867,112 | ZCA1 |
| 2019 | Strategies to Overcome Immune Resistance in Head and Neck Cancers1P01CA240239-01 | PAI, SARA ISABEL | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,786,322 | ZCA1 |
| 2019 | APOBEC MUTAGENESIS IN BREAST CANCER1P01CA234228-01A1 | HARRIS, REUBEN SYEE, DOUGLAS | UNIVERSITY OF MINNESOTA, MN | $1,656,507 | ZCA1 |
| 2019 | Androgen Receptor Action in Castration Resistant Prostate Cancer2P01CA163227-06A1 | BALK, STEVEN P. | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $1,546,415 | ZCA1 |
| 2019 | Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment2P01CA163222-06 | FISHER, DAVID E | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,516,688 | ZCA1 |
| 2019 | H. pylori-induced Inflammation and Gastric Cancer2P01CA116087-12 | PEEK, RICHARD M. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $1,419,975 | ZCA1 |
| 2019 | Molecular Tumorigenesis of Bladder Cancer2P01CA165980-06A1 | WU, XUE-RU | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $1,395,410 | ZCA1 |
| 2019 | Targeted Prevention for Non-Melanoma Skin Cancer1P01CA229112-01A1 | CURIEL-LEWANDROWSKI, CLARA | UNIVERSITY OF ARIZONA, AZ | $1,392,093 | ZCA1 |
| 2019 | Sphingolipids in Cancer Biology and Therapy2P01CA097132-16 | HANNUN, YUSUF AWNI | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $1,299,443 | ZCA1 |
| 2019 | The Role of the Integrated Stress Response in Cancer2P01CA165997-06A1 | KOUMENIS, CONSTANTINOS | UNIVERSITY OF PENNSYLVANIA, PA | $1,101,958 | ZCA1 |
| 2019 | Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care2P01CA180945-06 | BAKER, TIMOTHY BFIORE, MICHAEL C | UNIVERSITY OF WISCONSIN-MADISON, WI | $650,585 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.